Milestone Pharmaceuticals
The Director, Market Access at Milestone Pharmaceuticals oversees market access functions for the Cardamyst commercial launch and lifecycle management. This role involves managing vendor relationships, government pricing operations, payer contracting, and patient support programs while ensuring compliance with regulatory requirements.
Milestone Pharmaceuticals is a cardiovascular pharmaceutical company focused on developing and commercializing therapies for episodic cardiac rhythm disorders, including paroxysmal supraventricular tachycardia (PSVT) and atrial fibrillation with rapid ventricular rate (AFib-RVR). Its lead product, CARDAMYST™ (etripamil nasal spray), is now available through retail pharmacies across the U.S. and has received regulatory approval in China, with ongoing Phase 3 clinical trials advancing etripamil for AFib-RVR. The company focuses on self-administered treatments that allow patients to manage acute cardiac episodes outside of emergency or healthcare settings.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Milestone Pharmaceuticals.
Milestone Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
Senior Director Strategic Pricing
Azurity Pharmaceuticals
Director, National Accounts
Madrigal Pharmaceuticals
Director, National Accounts
Madrigal Pharmaceuticals
Director, Market Access Marketing (H&N)
Genmab
Part-Time Market Access Consultant
4-mag.com
Regional Account Director UHG Vertical, Health Plan & PBM CA, AZ, NV, HI
Takeda Pharmaceutical Company Limited